Table 5.
B | 95% CI for B | t | p-Value * | Adjusted R2 | F | ||
---|---|---|---|---|---|---|---|
Model 1 PCS at one-year follow-up | |||||||
(Constant) | 18.21 | 11.01 | 25.16 | 4.24 | 0.001 | 0.23 | 5.53 |
Pre-treatment PCS | 0.49 | 0.29 | 0.72 | 4.29 | 0.001 | ||
Female | 2.33 | −0.98 | 5.35 | 1.19 | 0.131 | ||
Children < 18 years | 0.27 | −2.45 | 2.97 | 0.19 | 0.838 | ||
Higher education | 0.39 | −3.17 | 4.03 | 0.25 | 0.832 | ||
Sleep problems at one-year follow-up | −2.08 | −4.77 | 0.39 | −1.40 | 0.111 | ||
Model 2 MCS at one-year follow-up | |||||||
(Constant) | 28.60 | 19.23 | 38.71 | 6.18 | 0.001 | 0.46 | 14.23 |
Pre-treatment MCS | 0.49 | 0.29 | 0.70 | 5.44 | 0.001 | ||
Female | −5.20 | −9.59 | −0.95 | −1.96 | 0.016 | ||
Children < 18 years | −4.04 | −7.57 | −0.36 | −2.08 | 0.040 | ||
Higher education | 4.71 | 0.21 | 9.29 | 2.16 | 0.045 | ||
Sleep problems at one-year follow-up | −6.20 | −10.49 | −2.18 | −3.02 | 0.006 |
* Values in bold indicate statistically significant differences.